EREG is a risk factor for the prognosis of patients with cervical cancer

BACKGROUND: Cervical cancer continues to threaten women's health worldwide. Identifying critical oncogenic molecules is important to drug development and prognosis prediction for patients with cervical cancer. Recent studies have demonstrated that epiregulin (EREG) is upregulated in various can...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Tianye, Feng, Ruijing, Chen, Bingxin, Zhou, Jianwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067667/
https://www.ncbi.nlm.nih.gov/pubmed/37020674
http://dx.doi.org/10.3389/fmed.2023.1161835

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067667/
https://www.ncbi.nlm.nih.gov/pubmed/37020674
http://dx.doi.org/10.3389/fmed.2023.1161835

Ejemplares similares